This public ISRCTN record appears to relate to schizophrenia. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.
This study is looking at care and outcomes for people with Schizophrenia or Bipolarity I. Taking part may give some people access to Iloperidone, but direct benefit is not guaranteed.
Multiple locations, including Little Rock
Why is this study shown?
This study is directly about Schizophrenia.
Schizophrenia, BipolarityDrugFrom 12 Years to 17 Years
This study is looking at whether Intervention arm: Prucalopride (tablets, over-encapsulated in a vegetarian shell and filled with Lactose Monohydrate Ph can help people with community population with psychotic-like experiences in the last 12 months or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether a digital support tool can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether a digital support tool can help people with Schizophrenia, schizotypal and delusional disorders or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
In United Kingdom
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaOtherFrom 16 Years to 100 Years
Countries
United Kingdom
Sponsor
Greater Manchester Mental Health NHS Foundation Trust
This observational study is following people with First episode psychosis and treatment resistant schizophrenia or Mental and Behavioural Disorders to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.